Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The design of a vaccine against Leishmaniasis

07.05.2008
The parasitology team at the “Severo Ochoa” Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.

There is evidence that proves the feasibility of such an effective vaccine design to prevent leishmaniasis. It is based on first identifying the compounds that the parasite uses to cause the pathology, isolating them, and finally introducing those compounds into the body in a safe manner, giving the immune system a chance to be alert against a possible infection.

Leishmaniasis is a disease caused by a protozoan intracellular parasite of the genus Leishmania that exhibits diverse symptoms and pathologies. These parasites are transmitted by a dipterous insect know as a sand fly (Phlebotomus), that acts as a vector for the disease and its genus differs depending on the geographical area. Human leishmaniasis is widely distributed around the globe and according to data from the WHO there are currently around 12 million people infected and 350 million people living under the threat of the disease in 88 different countries, mainly in tropical and subtropical regions.

In Spain, canine leishmaniasis constitutes a huge problem with 50% of infected dogs developing the pathology. In most cases it ends with the death of the animal, mainly because treatments are not efficient and have highly toxic side effects. Therefore, the house dog is considered the main hide-out for Leishmania infantum in the mediterranean area, playing a key role in the transmission of the parasite into humans through the sand fly. It should also be pointed out that the cases of leishmaniasis in patients suffering from advanced stages of AIDS with weakened immune systems is increasing. And although these cases are not as frequent, there are recently described cases of Leishmaniasis in cats and some horse species in many Mediterranean as well as South American countries.

Among the determining factors for the control of the disease, the virulence of the species of leishmania involved and the genetic predisposition of the host are crucial. Based on the symptoms of the disease, leishmania has been classified in to 4 different types: cutaneous, diffuse cutaneous, mucocutaneous and visceral. Many of the compounds of leishmania are invisible to the immune system, which allows the parasite to avoid our antimicrobial defences and establish an infection. Later, when the parasite starts to disseminate through the organism, other compounds (pathoantigens) are visible to the immune system and are vital for understanding the pathology.

In this context, the work carried out at the Molecular biology research centre Severo Ochoa (CSIC-UAM) by researchers from the parasitology group, formed among others by Doctors Javier Carrión and Carlos Alonso, has been focused on Histones, (proteins responsible for the packaging of DNA). As their latest published work (february edition of Vaccine) states: histones are one of the most important compounds that the parasite uses to define its degree of virulence. Through the isolation of the compounds and using different methodologies available in the molecular parasitology scientific field these researchers have developed immunization strategies that offer an outlook of a bright future in which a vaccine against leishmaniasis is a reality.

Oficina de Cultura Científica | alfa
Further information:
http://dx.doi.org/10.1016/j.vaccine.2007.12.051
http://www.uam.es

More articles from Health and Medicine:

nachricht Electrical 'switch' in brain's capillary network monitors activity and controls blood flow
27.03.2017 | Larner College of Medicine at the University of Vermont

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>